Aptus Capital Advisors, LLC

Position in MIST — Milestone Pharmaceuticals Inc.

CIK 1664193 FAIRHOPE, AL

Back to MIST Full portfolio

Position in MIST

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$454,863

+$121,366 QoQ

Shares Held

339,450

+21.1% QoQ

Ownership

0.273%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#18

of 78 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 2% Shared 0% None 98%

Common Shares in MIST Over Time

Shares Held

Position Value (USD)

Derivatives in MIST

reported options exposure · as of Jun 30, 2026

CallValue

$670

CallShares

500

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Aptus Capital Advisors, LLC holds $18,389,150 across 17 Biotechnology names. MIST ranks #6 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	13,787	$6,848,416
2	OCUL	Ocular Therapeutix, Inc	638,691	$6,271,945
3	RPRX	Royalty Pharma plc	24,206	$1,357,230
4	ALNY	Alnylam Pharmaceuticals, Inc.	3,389	$1,020,190
5	REGN	Regeneron Pharmaceuticals, Inc.	1,180	$735,777
6	MIST	Milestone Pharmaceuticals Inc. This page	339,450	$454,863
7	INCY	Incyte Corp	2,549	$288,954
8	EXEL	Exelixis, Inc.	5,118	$278,470

All Filings in MIST

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$454,863	339,450	+21.1%	Shares	Sole	2026-08-12
2026-06-30	$670	500	—	Call	Sole	2026-08-12
2026-03-31	$333,497	280,250	+6.5%	Shares	Sole	2026-05-11
2025-12-31	$531,664	263,200	+25.2%	Shares	Sole	2026-02-13
2025-09-30	$420,400	210,200	—	Shares	Sole	2025-11-12
No filing history on record for this holder in this stock.